Treatment of Myalgia, with the help of Homoeopathy

Role of Homoeopathy in the treatment of Myalgia

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/04/052037

Enrollment

Registered

2023-04-27

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

Intervention1: rhus tox 200: potency -200 dose - single dose(sos) route of administration - oral frequency - weekly once Control Intervention1: Not applicable: Not applicable

Eligibility

Inclusion criteria

Inclusion criteria: Subjects under pain atleast for 3 days of the week Subjects Should fulfil the diagnostic criteria

Exclusion criteria

Exclusion criteria: 1)Subjects having any auto immune illnesses or any pathological illnesses such as rheumatoid arthrits or osteoarthritis 2)Subjects having soreness due any trauma or injuries or any recent accident 3)Subjects below the age of 18 years and above the age of 40 years. 4)Subjects under any pain killers and nsaids already .

Design outcomes

Primary

Measure	Time frame
Numerical Pain rating scale test Mcgill pain questionnaire and case taking ,/interviews of various sportsmen.Timepoint: at the end of 48 weeks	—

Secondary

Measure	Time frame
the most effective medicine used in the treatment of myalgiaTimepoint: 48 weeks	—

Countries

India

Contacts

Public ContactDR Mrs SUSHMA SURESH MANHAS

B.V.D.U Homoeopathic medical college and Hospital ,Dept of Post Graduate and Research centre

sushma.manhas@bharatividyapeeth.edu9822322533

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026